1	Un	Un		C0205447_1	calificador_1	0-2	5_QUEST_clinical_caseMIR	SENT1	-	-
2	paciente	paciente	NCCS000	C0030705	persona	3-11	5_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	12-14	5_QUEST_clinical_caseMIR	SENT1	-	-
4	87	87		-	-	15-17	5_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	18-22	5_QUEST_clinical_caseMIR	SENT1	-	-
6	con	con	SPS00	C0332287	atributo	23-26	5_QUEST_clinical_caseMIR	SENT1	-	-
7	antecedentes	antecedente	NCMP000	C0332119_1	situación_1	27-39	5_QUEST_clinical_caseMIR	SENT1	-	-
8	de	de	SPS00	C0332119_2	situación_2	40-42	5_QUEST_clinical_caseMIR	SENT1	-	-
9	bronquitis	bronquitis	NCFN000	C0008677_1	trastorno_1	43-53	5_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
10	crónica	crónico	AQ0FS0	C0008677_2	trastorno_2	54-61	5_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
11	e	y	CC	C1706368	calificador	62-63	5_QUEST_clinical_caseMIR	SENT1	-	-
12	insuficiencia	insuficiencia	NCFS000	C0231179	hallazgo	64-77	5_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	cardiaca	cardiaco	AQ0FS0	-	-	78-86	5_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
14	,	,	Fc	-	-	86-87	5_QUEST_clinical_caseMIR	SENT1	-	-
15	ha	haber	VAIP3S0	-	-	88-90	5_QUEST_clinical_caseMIR	SENT1	-	-
16	sido	ser	VSP00SM	-	-	91-95	5_QUEST_clinical_caseMIR	SENT1	-	-
17	diagnosticado	diagnosticar	VMP00SM	-	-	96-109	5_QUEST_clinical_caseMIR	SENT1	-	-
18	de	de	SPS00	C0332285	atributo	110-112	5_QUEST_clinical_caseMIR	SENT1	-	-
19	colecistitis	colecistitis	NCFN000	C0149520_1	trastorno_1	113-125	5_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
20	aguda	agudo	AQ0FS0	C0149520_2	trastorno_2	126-131	5_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
21	Litiásica	litiásico	AQ0FS0	-	-	132-141	5_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
22	.	.	Fp	-	-	141-142	5_QUEST_clinical_caseMIR	SENT1	-	-

1	Tras	tras	SPS00	-	-	143-147	5_QUEST_clinical_caseMIR	SENT2	-	-
2	cuatro	cuatro		-	-	148-154	5_QUEST_clinical_caseMIR	SENT2	-	-
3	días	día	NCMP000	C0439228#C0332169	calificador	155-159	5_QUEST_clinical_caseMIR	SENT2	-	-
4	de	de	SPS00	C0332285	atributo	160-162	5_QUEST_clinical_caseMIR	SENT2	-	-
5	hospitalización	hospitalización	NCFS000	-	-	163-178	5_QUEST_clinical_caseMIR	SENT2	-	-
6	en	en	SPS00	C1720294#C0332285	calificador#atributo	179-181	5_QUEST_clinical_caseMIR	SENT2	-	-
7	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	182-193	5_QUEST_clinical_caseMIR	SENT2	-	-
8	con	con	SPS00	C3472561_1	hallazgo_1	194-197	5_QUEST_clinical_caseMIR	SENT2	-	-
9	dieta	dieta	NCFS000	C3472561_2	hallazgo_2	198-203	5_QUEST_clinical_caseMIR	SENT2	-	-
10	absoluta	absoluto	AQ0FS0	C3472561_3	hallazgo_3	204-212	5_QUEST_clinical_caseMIR	SENT2	-	-
11	,	,	Fc	-	-	212-213	5_QUEST_clinical_caseMIR	SENT2	-	-
12	sueroterapia	sueroterapia	NCFS000	-	-	214-226	5_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
13	,	,	Fc	-	-	226-227	5_QUEST_clinical_caseMIR	SENT2	-	-
14	piperacilina	piperacilina	NC00SC0	C0031955	producto#sustancia	228-240	5_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
15	/	/	Fh	-	-	240-241	5_QUEST_clinical_caseMIR	SENT2	-	-
16	Tazobactam	tazobactam	NC00SC0	C0075870	sustancia#producto	241-251	5_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
17	,	,	Fc	-	-	251-252	5_QUEST_clinical_caseMIR	SENT2	-	-
18	el	el	DA0MS0	-	-	253-255	5_QUEST_clinical_caseMIR	SENT2	-	-
19	paciente	paciente	NCCS000	C0030705	persona	256-264	5_QUEST_clinical_caseMIR	SENT2	-	-
20	continúa	continuar	VMIP3S0	-	-	265-273	5_QUEST_clinical_caseMIR	SENT2	-	-
21	con	con	SPS00	C0332287	atributo	274-277	5_QUEST_clinical_caseMIR	SENT2	-	-
22	fiebre	fiebre	NCFS000	C0015967	hallazgo	278-284	5_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
23	,	,	Fc	-	-	284-285	5_QUEST_clinical_caseMIR	SENT2	-	-
24	dolor	dolor	NCMS000	C0000737_1	hallazgo_1	286-291	5_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
25	abdominal	abdominal	NC00SC0	C0000737_2	hallazgo_2	292-301	5_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
26	persistente	persistente	AQ0CS0	C0205322#C0549178	calificador	302-313	5_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
27	y	y	CC	C1706368	calificador	314-315	5_QUEST_clinical_caseMIR	SENT2	-	-
28	leucocitosis	leucocitosis	NCFN000	C0023518#C0750426	trastorno#hallazgo	316-328	5_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
29	.	.	Fp	-	-	328-329	5_QUEST_clinical_caseMIR	SENT2	-	-

1	La	el	DA0FS0	-	-	330-332	5_QUEST_clinical_caseMIR	SENT3	-	-
2	actitud	actitud	NCFS000	C0004271	entidad_observable	333-340	5_QUEST_clinical_caseMIR	SENT3	-	-
3	más	más	RG	C0205172	calificador	341-344	5_QUEST_clinical_caseMIR	SENT3	-	-
4	adecuada	adecuar	VMP00SF	-	-	345-353	5_QUEST_clinical_caseMIR	SENT3	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	354-356	5_QUEST_clinical_caseMIR	SENT3	-	-
6	este	este	DD0MS0	-	-	357-361	5_QUEST_clinical_caseMIR	SENT3	-	-
7	momento	momento	NCMS000	C0040223#C0563597	calificador#fuerza_física	362-369	5_QUEST_clinical_caseMIR	SENT3	-	-
8	sería	ser	VSIC1S0	-	-	370-375	5_QUEST_clinical_caseMIR	SENT3	-	-
9	:	:	Fd	-	-	375-376	5_QUEST_clinical_caseMIR	SENT3	-	-
10	.	.	Fp	-	-	376-377	5_QUEST_clinical_caseMIR	SENT3	-	-

